Company:  OPGEN INC (OPGN)
Form Type:  4
Filing Date:  1/27/2022 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  301-869-9683 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
0.0113 (1.63%)  
Trade Time: 
May 26  
Market Cap: 
Trade OPGN now with

© 2023  
Description of Business
OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. Along with its subsidiaries, Curetis GmbH and Ares Genetics GmbH, the Company is developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. The Company's current product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, NGS technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE-IVD-marked PCR-based SARS-CoV-2 test kit.
Register and access this filing in:     
  FORM 4

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.